Analyst Giada Cabrino of Intesa Sanpaolo maintained a Buy rating on Fine Foods & Pharmaceuticals N.T.M. SpA (FF – Research Report), with a price target of €11.90.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Giada Cabrino’s rating is based on several positive indicators for Fine Foods & Pharmaceuticals N.T.M. SpA. The company achieved its highest ever EBITDA and margin in the first quarter of 2025, driven by organic growth and traditional business strategies. This strong performance, despite a slight decline in overall sales, highlights the company’s ability to improve profitability through cost efficiencies and strategic investments in production capacity.
Furthermore, Fine Foods has a robust order backlog and multi-year agreements that support a positive outlook for the fiscal year 2025. The company’s strategic initiatives are expected to enhance its competitive position and market share across its core business units. Despite some caution regarding the growth of the Nutra business unit, the overall growth trajectory remains strong, supported by improved competitive positioning and increased synergies between business units. These factors contribute to the Buy rating, with an expectation of continued market outperformance.
In another report released on May 9, Intermonte also maintained a Buy rating on the stock with a €11.50 price target.
FF’s price has also changed slightly for the past six months – from EUR8.160 to EUR7.620, which is a -6.62% drop .
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue